Valneva: US Commission Recommends Chikungunya Vaccine |

02/29/2024, 2049 characters

The US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has decided to recommend Valneva's single-dose chikungunya vaccine IXCHIQ® for the prevention of chikungunya virus disease. Juan Carlos Jaramillo, Valneva's Chief Medical Officer, commented: “Chikungunya poses a significant risk to people traveling or living in areas where the chikungunya virus and the mosquitoes that transmit it are common. IXCHIQ® offers benefits to travelers, vacationers, visiting family, as well as those doing business, assignments or laboratory work. . We welcome the ACIP recommendation identifying IXCHIQ® as the only approved and prescribed vaccine for the target population. We will continue to work with regulatory authorities worldwide. Enable access to IXCHIQ® in all regions.”

ACIP recommendations are forwarded to CDC and the director of the US Department of Health and Human Services for review and approval. Once approved, final recommendations will be published in the Future Morbidity and Mortality Weekly Report (MMWR) to inform health care providers about the appropriate use of the vaccine.

ACIP recommends IXCHIQ® for individuals ≥18 years of age traveling to a country or region with chikungunya. In addition, it may be considered for persons traveling to a country or region without an outbreak but with evidence of CHIKV transmission in the past five years and persons >65 years of age and expected to have at least moderate mosquito exposure. At least two weeks, overall), or those traveling for longer periods (six months or more, overall). ACIP also recommends chikungunya vaccine for laboratory workers who may be exposed to chikungunya virus.

See also  Partial results: Second round of presidential election in Slovakia

BSN Podcasts

Christian Trastevere: Vienna Stock Exchange Chat

Vienna Stock Exchange Party #598: Restart the Vienna Financial Market? Do&Co is back at an all-time high, good to be a general contractor

Photo credit

1. Valneva, Laboratory, Vaccine, Credit: Valneva , (© Submitter) >> Open at

Stocks on the radar:obscenity, Vienna Airport, UBM, Print, Rosenbauer, AustriaGard Holdings AG, Collaboration, Stick to it, Pawag, EVN, Austrian post, AT&S, Strawback, Acrana, Immofinance, Telecom Austria, MARINOMAT BIOTECH, Peer Mobility, Yes yes, RHI Magnesita, Adigo Bank, CA Yes, The first group, Unica, V.I.G, Weinerberger, Siemens Energy, The BMW, Porsche Automobile Holdings, Daimler Trucks Hld…, Heidelberg Cement.

Random partner

Share 3
The Munich FinTech pioneer was founded in 2000 and provides IT solutions and editorial content to private and business clients. BörseGo AG is known for its godmode trader and mentors. Godmode Trader Portal provides online solutions for trading, technical analysis and investment strategies. Guides is a financial market analysis and multi-brokerage platform.

>> Visit 68 other partners

Valneva, laboratory, vaccine, credit: Valneva, (© provider)

Author of the book

Christine Petzwinkler

Stock market social network/magazine

Leave a Reply

Your email address will not be published. Required fields are marked *